Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan-R Targan

Showing results (101-110 of 181) with videos related to

Pageof 19
Sort By:
The American Journal of Gastroenterology|January 19, 2005
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximabKonstantinos A Papadakis, Omid A Shaye, Eric A Vasiliauskas, et al.
Plos One|March 6, 2009
IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A proteinKathrin S Michelsen, Lisa S Thomas, Kent D Taylor, et al.
The American Journal of Gastroenterology|September 17, 2009
Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel diseaseGil Y Melmed, Nik Agarwal, Robert W Frenck, et al.
The American Journal of Pathology|December 6, 2011
Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosisRobert Barrett, Xiaolan Zhang, Hon Wai Koon, et al.
Gut|October 16, 2010
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitisWilliam J Sandborn, Jean Frederic Colombel, Matthew Frankel, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 23, 2018
Enhanced Utilization of Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids Using Microengineered ChipsMichael J Workman, John P Gleeson, Elissa J Troisi, et al.
Journal of Crohn'S & Colitis|March 17, 2019
Ileal Gene Expression Data from Crohn's Disease Small Bowel Resections Indicate Distinct Clinical SubgroupsAlka A Potdar, Dalin Li, Talin Haritunians, et al.
Gastroenterology|July 27, 2023
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation StudyAndres J Yarur, Alexandra Bruss, Andrea Moosreiner, et al.
Gastroenterology|August 2, 2003
6-thioguanine can cause serious liver injury in inflammatory bowel disease patientsMarla C Dubinsky, Eric A Vasiliauskas, Hardeep Singh, et al.
Journal of Crohn'S & Colitis|December 10, 2020
Pre-pouch Ileitis is Associated with Development of Crohn's Disease-like Complications and Pouch FailureGaurav Syal, Ron Shemtov, Nirupama Bonthala, et al.
Pageof 19

Showing results (101-110 of 181) with videos related to

Sort By:
Pageof 19
The American Journal of Gastroenterology|January 19, 2005
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximabKonstantinos A Papadakis, Omid A Shaye, Eric A Vasiliauskas, et al.
Plos One|March 6, 2009
IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A proteinKathrin S Michelsen, Lisa S Thomas, Kent D Taylor, et al.
The American Journal of Gastroenterology|September 17, 2009
Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel diseaseGil Y Melmed, Nik Agarwal, Robert W Frenck, et al.
The American Journal of Pathology|December 6, 2011
Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosisRobert Barrett, Xiaolan Zhang, Hon Wai Koon, et al.
Gut|October 16, 2010
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitisWilliam J Sandborn, Jean Frederic Colombel, Matthew Frankel, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 23, 2018
Enhanced Utilization of Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids Using Microengineered ChipsMichael J Workman, John P Gleeson, Elissa J Troisi, et al.
Journal of Crohn'S & Colitis|March 17, 2019
Ileal Gene Expression Data from Crohn's Disease Small Bowel Resections Indicate Distinct Clinical SubgroupsAlka A Potdar, Dalin Li, Talin Haritunians, et al.
Gastroenterology|July 27, 2023
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation StudyAndres J Yarur, Alexandra Bruss, Andrea Moosreiner, et al.
Gastroenterology|August 2, 2003
6-thioguanine can cause serious liver injury in inflammatory bowel disease patientsMarla C Dubinsky, Eric A Vasiliauskas, Hardeep Singh, et al.
Journal of Crohn'S & Colitis|December 10, 2020
Pre-pouch Ileitis is Associated with Development of Crohn's Disease-like Complications and Pouch FailureGaurav Syal, Ron Shemtov, Nirupama Bonthala, et al.
Pageof 19